Price Move History
- Daily moves over 5%
- 72 142 sessions, November 14, 2025 to November 16, 2026
- Largest daily move
- +238.1% close of July 7, 2026
- 1-year change
- -55% closing prices, November 14, 2025 to November 16, 2026
- 1-month change
- -14.7% closing prices, October 14, 2026 to November 16, 2026
Company Description
Greenway Greenhouse Cannabis Corporation (OTCQB: GWAYF), also referenced as Greenway Greenhouse Cannabis, is a federally licensed cultivator for the Canadian cannabis marketplace. The company is headquartered in Kingsville, Ontario, and describes itself as a cultivator of high-quality greenhouse cannabis for the Canadian market. Its shares trade in Canada on the Canadian Securities Exchange under the symbol GWAY and in the United States on the OTCQB under the symbol GWAYF.
According to the company, Greenway focuses on greenhouse cultivation of cannabis and leverages agriculture and cannabis expertise in its aspiration to be a leading cannabis cultivator in Canada. Public disclosures repeatedly highlight an emphasis on cultivation performance, cost discipline, and efficiency in greenhouse operations. Greenway reports that it operates with active greenhouse cultivation space and has discussed bringing additional built-out capacity into production in a measured, demand-driven way.
Business focus and operating model
Greenway describes its core business as cultivating cannabis in greenhouse facilities for the Canadian marketplace. The company has reported supplying cannabis into wholesale channels in Canada and has also discussed domestic consumer-packaged goods (CPG) activities through brands it either developed or acquired. In its public communications, Greenway notes that it has introduced brands such as MillRite and EPIC Cannabis Co to the Canadian recreational market and has acquired additional cannabis CPG brands and related intellectual property from Choice Growers Cannabis Inc.
The company has indicated that it participates in wholesale cannabis markets and has expanded into branded consumer products sold through the Canadian recreational market. Greenway has also discussed international wholesale activities, stating that its cannabis products have reached multiple jurisdictions across Europe and Australia and that it has an international wholesale program focused on regulated medical cannabis markets.
Greenhouse cultivation and efficiency
Greenway frequently emphasizes greenhouse cultivation efficiency in its disclosures. The company has described efforts to optimize crop scheduling, strain selection, and facility utilization to improve yields and cost control. It has also reported applying to Health Canada for dedicated propagation and vegetation space at a facility in Leamington, Ontario, with the goal of increasing the number of crop rotations per year and improving biomass throughput.
Management commentary in company news releases links these operational changes to improved margins and a focus on aligning production with profitable sales channels. Greenway has stated that it aims to maintain strong operating leverage while avoiding unnecessary expansion-related risk by utilizing already built cultivation capacity in a deliberate way.
Domestic CPG and brand portfolio
In addition to wholesale activities, Greenway has disclosed a growing presence in the Canadian cannabis CPG segment. The company reports that it introduced the MillRite and EPIC Cannabis Co brands to the Canadian recreational market. It has highlighted MillRite-branded pre-roll products, including references to size segments such as 2x0.5g pre-rolls and 10x0.35g pre-rolls, as well as a milled-flower product under the MillRite brand called Blue Crush.
Greenway has also announced the acquisition of all consumer-packaged goods brands, SKUs, listings, trademarks, goodwill, and associated intellectual property from Choice Growers Cannabis Inc. This acquisition includes brands such as Grapefruit God Bud (also referred to as Grape God), The Jeffrey, Watermelon Pebbles, Pink Lemonade, Duke Nukem, Tangerine Dream, and Blackberry Cheesecake. Greenway states that this transaction is intended to expand its CPG presence, increase the number of SKUs it offers in Ontario, and introduce its products into additional Canadian provinces.
International wholesale and medical cannabis markets
Greenway has publicly discussed an international wholesale program focused on medical cannabis markets. The company reports that its cannabis products have reached multiple jurisdictions across Europe as well as Australia in its first full year participating in international markets. It attributes this activity to its ability to meet regulatory, logistical, and compliance requirements of global medical cannabis markets.
In the United Kingdom, Greenway has announced a supply agreement with 4C LABS, which it describes as a medical cannabis company focused on providing UK pharmacies, clinics, and patients with medical cannabis products. Under this agreement, Greenway expects to supply high-quality dried flower to 4C LABS, which is described as an importer and distributor of cannabis-based pharmaceuticals in the United Kingdom. The company has characterized this partnership as a dedicated pathway into the UK medical cannabis market and distinct from its other international distribution efforts.
Licensing and certifications
Greenway states that it is a federally licensed cultivator under the Canadian regulatory framework for cannabis. In its public communications, the company has also reported receiving CUMS-GAP and GACP certifications, which it identifies as enabling its cannabis products to be sold internationally. These certifications are referenced in connection with the company’s international wholesale activities and its participation in global medical cannabis markets.
Growth, capacity, and strategic priorities
In year-in-review and financial statement news releases, Greenway has described periods of revenue growth, increased grams sold, and higher average sales prices per gram compared to prior periods. The company links these results to expanded cultivation space utilization, operational improvements, and diversification into CPG and international wholesale markets.
Greenway has stated that it has completed the build-out of additional cultivation space, which it expects to bring into production as demand develops across its sales channels. Management commentary emphasizes a strategy of using existing built-out capacity to increase total production capability without requiring significant new capital expenditures. The company has also discussed applying for new propagation space to support more crop rotations per year and has highlighted the importance of aligning production with wholesale, branded product, and international sales channels.
Capital markets and corporate actions
Greenway’s disclosures include information about share issuances related to convertible debentures and consulting arrangements. The company has reported issuing common shares arising from convertible debentures and issuing shares to a consultant and its assignees as part of a work fee for corporate-finance advisory services. These issuances are described as being subject to hold periods in accordance with Canadian securities laws and Canadian Securities Exchange policies.
The company has also noted that its financial statements and related Management’s Discussion and Analysis are available under its profile on a Canadian securities disclosure platform. Greenway’s news releases frequently include standard cautionary language regarding securities law restrictions and clarify that the Canadian Securities Exchange has not approved or disapproved the contents of those releases.
Position within the healthcare and cannabis sector
Within the broader healthcare sector, Greenway is classified in the "Drug Manufacturers - Specialty & Generic" industry category for market data purposes, but its own disclosures consistently describe its primary business as greenhouse cannabis cultivation for the Canadian market. The company’s activities span domestic wholesale, Canadian recreational CPG brands, and international medical cannabis wholesale channels.
According to its public statements, Greenway seeks to combine greenhouse cultivation expertise, cost discipline, and brand development to participate in both wholesale and consumer-facing segments of the cannabis market. Its reported certifications and international agreements indicate a focus on regulated medical cannabis markets outside Canada, while its Canadian operations include both wholesale and branded recreational products.
Stock Performance
Greenway Grenhse Cannabis (GWAYF) closed at $0.0580 on November 16, 2026. Over the past 12 months, the price has lost 55.0%.
GWAYF Metrics & Rankings
Price returns through November 16, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Greenway Grenhse Cannabis has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include earnings. View all GWAYF news →
SEC Filings
Short Interest History
Short interest in Greenway Grenhse Cannabis (GWAYF) currently stands at 600 shares, down 68.4% from the previous reporting period, representing 0.0% of the float. Since November 2025, short interest has increased by 25.8%.
Days to Cover History
Days to cover for Greenway Grenhse Cannabis (GWAYF) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 8.7 days.
GWAYF Company Profile & Sector Positioning
Greenway Grenhse Cannabis (GWAYF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing GWAYF often look at related companies in the same sector, including Avant Brands Inc (AVTBF), FLUENT Corp (CNTMF), PharmaCielo Ltd (PCLOF), Rhelion Life Sciences CP (TRUFF), and Orexo AB (ORXOF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate GWAYF's relative position within its industry.